Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000367739 http://scihub22266oqcxt.onion/10.1159/000367739 C4608659!4608659!26675172     free     free     free       Liver+Cancer 2015 ; 4 (3): 165-75 Nephropedia Template TP {{tp|p=26675172|t=2015. Surgical and Locoregional Therapy of HCC: TACE |pdf=|usr=}}{{26675172}} gab.com Text Surgical and Locoregional Therapy of HCC: TACE JO: Liver Cancer http://www.kidney.de/pget.php?&tw=1&pmid=26675172 #FOAvip Transcatheter arterial chemoembolization (TACE) is performed worldwide for patients with intermediate-stage hepatocellular carcinoma (HCC). TACE has produced survival advantages in two randomized controlled trials and a meta-analysis, and is currently the mainstay of treatment for this stage of HCC. However, there are currently no global guidelines regarding the dose, choice or combination of cytotoxic agents for TACE; therefore, it is difficult to compare data from different TACE studies. In Japan, most of the TACE procedures have been based on iodized oil as conventional TACE, utilizing the microembolic and drug-carrying characteristic of iodized oil. Superselective TACE with lipiodol is the primary TACE procedure that has reported satisfactory levels of local control associated with a lower risk of complications. Conversely, TACE performed using drug-eluting beads has been widely used in western countries, and this has shown similar tumor response and median survival compared to conventional TACE. Moreover, the combination of TACE and molecular targeted agents is now ongoing to evaluate the synergistic effect. In this review, the indication, technical issues, and complications of TACE are reviewed. Twit Text FOAVip Surgical and Locoregional Therapy of HCC: TACE ????Liver Cancer http://www.kidney.de/pget.php?&tw=1&pmid=26675172 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26675172 #FOAvip English Wikipedia <ref>{{Cite pmid|26675172}}</ref> Surgical and Locoregional Therapy of HCC: TACE #MMPMID26675172 Tsurusaki M; Murakami T Liver Cancer 2015[Sep]; 4 (3): 165-75 PMID26675172show ga Transcatheter arterial chemoembolization (TACE) is performed worldwide for patients with intermediate-stage hepatocellular carcinoma (HCC). TACE has produced survival advantages in two randomized controlled trials and a meta-analysis, and is currently the mainstay of treatment for this stage of HCC. However, there are currently no global guidelines regarding the dose, choice or combination of cytotoxic agents for TACE; therefore, it is difficult to compare data from different TACE studies. In Japan, most of the TACE procedures have been based on iodized oil as conventional TACE, utilizing the microembolic and drug-carrying characteristic of iodized oil. Superselective TACE with lipiodol is the primary TACE procedure that has reported satisfactory levels of local control associated with a lower risk of complications. Conversely, TACE performed using drug-eluting beads has been widely used in western countries, and this has shown similar tumor response and median survival compared to conventional TACE. Moreover, the combination of TACE and molecular targeted agents is now ongoing to evaluate the synergistic effect. In this review, the indication, technical issues, and complications of TACE are reviewed. äSurgical and Locoregional Therapy of HCC: TACE (epmc).pdf DeepDyve Pubget Overpricing